House Bill 122

Actions
Last Action 01/05/21: to Committee on Committees (H)
Title AN ACT relating to the establishment of emergency insulin programs and declaring an emergency.
Bill Documents Introduced
Bill Request Number 968
Sponsors P. Minter, K. Flood, A. Scott, S. Westrom
Summary of Original Version Create various new sections of KRS Chapter 211 to define terms; establish the urgent-need insulin program and the continuing access to insulin program; establish eligibility guidelines for both programs; establish the application process; establish the process by which insulin is dispensed to eligible individuals; establish the responsibilities of insulin manufacturers for facilitating the dispensing of insulin to eligible individuals; establish the responsibilities of the Kentucky Board of Pharmacy for administering the program; require manufacturers to maintain privacy of all data obtained; require manufacturers to annually report certain information to the board; require the board to report certain information to the General Assembly upon request; establish penalties; EMERGENCY.
Index Headings of Original Version Diseases - Diabetes, urgent-need insulin program and continuing access to insulin program, establishment
Drugs and Medicines - Urgent-need insulin program and continuing access to insulin program, establishment
Effective Dates, Emergency - Urgent-need insulin program and continuing access to insulin program, establishment
Pharmacists - Urgent-need insulin program and continuing access to insulin program, establishment
State Agencies - Board of Pharmacy, continuing access to insulin program
State Agencies - Board of Pharmacy, urgent-need insulin program
Administrative Regulations and Proceedings - Board of Pharmacy, continuing access to insulin program
Administrative Regulations and Proceedings - Board of Pharmacy, urgent-need insulin program
Boards and Commissions - Board of Pharmacy, continuing access to insulin program, establishment
Boards and Commissions - Board of Pharmacy, urgent-need insulin program, establishment
Reports Mandated - Insulin manufacturers, urgent-need and continuing access to insulin programs, requirement

Actions

Top
12/10/20
  • Prefiled by the sponsor(s).
01/05/21
  • introduced in House
  • to Committee on Committees (H)


Last updated: 4/14/2021 8:30 AM (EDT)
To receive notice when the record is updated follow @LRCTweetBot.